CIDE-C Antibodies

Santa Cruz Biotechnology provides a broad selection of CIDE-C monoclonal antibodies for research focused on understanding cellular processes. CIDE-C monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CIDE-C, or Cell Death Inducing DFFA-Like Effector C, plays a critical role in apoptosis and cellular homeostasis. CIDE-C actively participates in the regulation of cell death pathways, maintaining tissue integrity and function. Research involving CIDE-C continues to reveal important insights into various diseases, including cancer and neurodegenerative disorders. Investigating CIDE-C expression patterns helps researchers understand its role in different tissue types and cellular conditions. Studying CIDE-C interactions with other molecules provides valuable information about cell death mechanisms and potential therapeutic targets. Examining CIDE-C activity in various disease models contributes to the development of new treatment strategies. Santa Cruz Biotechnology monoclonal antibodies for CIDE-C research support scientists worldwide in advancing our understanding of cellular processes and disease mechanisms.